Marina Natoli

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Venues

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

Science translational medicine

Molecular cancer therapeutics

University of Basel

University College London (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Basel

Switzerland

Postdoctoral researcher

Imperial College London Jul 04 2016

United Kingdom

PhD Candidate :: Surgery and Cancer

Education History

University College London Sep 01 2013 - Sep 01 2014

United Kingdom

MSC

Publications

Pavlina Spiliopoulou, Sarah Spear, Hasan B Mirza, Ian Garner, Lynn McGarry, Fabio Grundland-Freile, Zhao Cheng, Darren P Ennis, Nayana Iyer, Sophie McNamara, Marina Natoli, Susan Mason, Karen Blyth, Peter D Adams, Patricia Roxburgh, Matthew John Fuchter, Robert Brown, Iain A McNeish
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma. Molecular cancer therapeutics 21 (4) (2022)
Marina Natoli, Klas Hatje, Pratiksha Gulati, Fabian Junker, Petra Herzig, Zhiwen Jiang, Iakov I Davydov, Markus Germann, Marta Trüb, Daniel Marbach, Adrian Zwick, Patrick Weber, Stefan Seeber, Mark Wiese, Didier Lardinois, Viola Heinzelmann-Schwarz, Robert Rosenberg, Lothar Tietze, Kirsten D Mertz, Pablo Umaña, Christiane Neumann, Laura Codarri-Deak, Henry Kao, Alfred Zippelius
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors. Journal for immunotherapy of cancer 10 (11) (2022)
Nicole Kirchhammer, Marcel Philipp Trefny, Marina Natoli, Dominik Brücher, Sheena N Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina Magdalena Bartoszek, Mélanie Buchi, Markus Schmid, Daniel Breu, K Patricia Hartmann, Polina Zaytseva, Daniela S Thommen, Heinz Laubli, Jan Philipp Böttcher, Michal A Stanczak, Abhishek S Kashyap, Andreas Plückthun, Alfred Zippelius
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity. Science translational medicine 14 (653) (2022)
Natalia Rodrigues Mantuano, Marina Natoli, Alfred Zippelius, Heinz Laubli
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Marina Natoli, John Gallon, Haonan Lu, Ala Amgheib, David James Pinato, Francesco A Mauri, Teresa Marafioti, Ayse U Akarca, Ines Ullmo, Jacey Ip, Eric O Aboagye, Robert Brown, Anastasios Karadimitris, Sadaf Ghaem-Maghami
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression. Journal for immunotherapy of cancer 9 (1) (2021)
Marina Natoli, Nair Bonito, James D Robinson, Sadaf Ghaem-Maghami, Yumeng Mao
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade. Cancer immunology, immunotherapy : CII 69 (8) (2020)
John Wahba, Marina Natoli, Lynsey M Whilding, Ana C Parente-Pereira, Youngrock Jung, Stefania Zona, Eric Wing-Fai Lam, J Richard Smith, John Maher, Sadaf Ghaem-Maghami
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer. Cancer immunology, immunotherapy : CII 67 (11) (2018)

Marina Natoli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marina Natoli